Postpartum depression pill zuranolone yields "significant improvements," clinical trial data shows - CBS News
cbsnews.comSubmitted by cbsnews1121 in health
Zuranolone is not yet approved by the Food and Drug Administration, but the agency is expected to make a decision in early August.